Study of Efficacy of Ranibizumab in Different Regimens in Patients With Diabetic Macula Edema

NCT02366468 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

135

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Retinopathy

Interventions

DRUG: ranibizumab 0.5 mg

Sponsor

Novartis Pharmaceuticals